Taichun Qin, Ph.D.
Affiliations: | 2008 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
PharmacologyGoogle:
"Taichun Qin"Parents
Sign in to add mentor| Jean-Pierre Issa | grad student | 2008 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
| (Maximizing efficacy of the hypomethylating drug 5-aza-2'-deoxycytidine in human leukemia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jin C, Qin T, Barton MC, et al. (2015) Minimal Role of Base Excision Repair in TET-Induced Global DNA Demethylation in HEK293T Cells. Epigenetics. 0 |
| Qin T, Si J, Raynal NJ, et al. (2015) Epigenetic synergy between decitabine and platinum derivatives. Clinical Epigenetics. 7: 97 |
| Qin T, Castoro R, El Ahdab S, et al. (2011) Mechanisms of resistance to decitabine in the myelodysplastic syndrome. Plos One. 6: e23372 |
| Si J, Boumber YA, Shu J, et al. (2010) Chromatin remodeling is required for gene reactivation after decitabine-mediated DNA hypomethylation. Cancer Research. 70: 6968-77 |
| Yan Z, Shu J, Si J, et al. (2010) Abstract LB-84: DNA methylation centers in CpG-island promoters are context-specific Cancer Research. 70 |
| Qin T, Jelinek J, Si J, et al. (2009) Mechanisms of resistance to 5-aza-2'-deoxycytidine in human cancer cell lines. Blood. 113: 659-67 |
| Qin T, Youssef EM, Jelinek J, et al. (2007) Effect of cytarabine and decitabine in combination in human leukemic cell lines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4225-32 |
| Shu J, Jelinek J, Chang H, et al. (2006) Silencing of bidirectional promoters by DNA methylation in tumorigenesis. Cancer Research. 66: 5077-84 |